Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis

被引:10
作者
Dai, Dan [1 ,2 ]
Wu, Haoran [2 ,3 ]
He, Chunyan [1 ,2 ]
Wang, Xinmiao [3 ]
Luo, Yiqi [2 ]
Song, Ping [1 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Dermatol, Beijing 100053, Peoples R China
[2] Beijing Univ Chinese Med, Grad Coll, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Endocrinol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Psoriasis vulgaris; traditional Chinese medicine; pharmacological mechanisms; randomized controlled trials; SKIN-LESIONS; BALB/C MICE; VEGF EXPRESSION; HERBAL MEDICINE; TANSHINONE IIA; CELLS; DIFFERENTIATION; APOPTOSIS; CARDIOMYOCYTES; PROLIFERATION;
D O I
10.1080/09546634.2020.1789048
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis vulgaris (PV) not only affects patients' skin health but also increases the risk of coronary heart disease and diabetes, which brings both physical and mental harms. Its pathogenesis is complex, and the multitarget effect of traditional Chinese medicine (TCM) is especially advantageous. Because a considerable number of randomized controlled trials related to TCM exhibit design defects, small sample size, or inadequate intervention time, so the status of TCM in the treatment of PV cannot be fully clarified. We reviewed the controlled clinical trials published over the past decade and selected 17 high-quality articles from over 2000 papers. The results suggest that TCM might be beneficial for decrease in PASI scores, thus, TCM might be an effective alternative therapy for PV management. The safety of TCM on PV was also assessed in our analysis. The more strictly designed and long-term observations of TCM for PV are supposed to be conducted in the future.
引用
收藏
页码:671 / 681
页数:11
相关论文
共 55 条
[1]   How does methotrexate work? [J].
Alqarni, Adel M. ;
Zeidler, Martin P. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (02) :559-567
[2]  
[Anonymous], 2015, LIAONING J TRADIT CH, V42, P547
[3]   Psoriasis [J].
Boehncke, Wolf-Henning ;
Schoen, Michael P. .
LANCET, 2015, 386 (9997) :983-994
[4]   Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis [J].
Borren, Nienke Z. ;
Ananthakrishnan, Ashwin N. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) :1736-+
[5]   Methotrexate and its mechanisms of action in inflammatory arthritis [J].
Cronstein, Bruce N. ;
Aune, Thomas M. .
NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (03) :145-154
[6]  
Cui Y., 2019, J SICHUAN TRADIT CHI, V37, P151
[7]   Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry [J].
Dauden, Esteban ;
Carretero, Gregorio ;
Rivera, Raquel ;
Ferrandiz, Carlos ;
Llamas-Velasco, Mar ;
de la Cueva, Pablo ;
Belinchon, Isabel ;
Jose Gomez-Garcia, Francisco ;
Herrera-Acosta, Enrique ;
Patricia Ruiz-Genao, Diana ;
Ferran-Farres, Marta ;
Alsina, Merce ;
Baniandres-Rodriguez, Ofelia ;
Luis Sanchez-Carazo, Jose ;
Sahuquillo-Torralba, Antonio ;
Rodriguez Fernandez-Freire, Lourdes ;
Vilar-Alejo, Jaime ;
Garcia-Donoso, Carmen ;
Manuel Carrascosa, Jose ;
Herrera-Ceballos, Enrique ;
Luis Lopez-Estebaranz, Jose ;
Botella-Estrada, Rafael ;
Segovia-Munoz, Eva ;
Angel Descalzo, Miguel ;
Garcia-Doval, Ignacio .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) :139-150
[8]   Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway [J].
Di, Ting-Ting ;
Ruan, Zhi-Tong ;
Zhao, Jing-Xia ;
Wang, Yan ;
Liu, Xin ;
Wang, Ying ;
Li, Ping .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 32 :32-38
[9]  
Ding R., 2017, MOD J INTEGR TRADIT, V26, P2030
[10]   Psoriasis [J].
Greb, Jacqueline E. ;
Goldminz, Ari M. ;
Elder, James T. ;
Lebwohl, Mark G. ;
Gladman, DafnaD. ;
Wu, Jashin J. ;
Mehta, Nehal N. ;
Finlay, Andrew Y. ;
Gottlieb, Alice B. .
NATURE REVIEWS DISEASE PRIMERS, 2016, 2